IM Cannabis (NASDAQ: IMCC) to report results Nov 13 at 9:00am ET before market open

November 6, 2025

Rhea-AI Impact

Rhea-AI Sentiment

(Neutral)

Tags


conferences
earnings

Rhea-AI Summary

IM Cannabis (NASDAQ: IMCC) will report operational and financial results for the third quarter 2025, which ended September 30, 2025.

The company said results will be released on Thursday, November 13, 2025, before the market opens. IM Cannabis operates in Israel and Germany.

IM Cannabis (NASDAQ: IMCC) comunicherà i risultati operativi e finanziari del terzo trimestre 2025, che si è chiuso il 30 settembre 2025.

La società ha detto che i risultati saranno rilasciati giovedì 13 novembre 2025, prima dell’apertura del mercato. IM Cannabis opera in Israele e Germania.

IM Cannabis (NASDAQ: IMCC) reportará resultados operativos y financieros del tercer trimestre de 2025, que finalizó el 30 de septiembre de 2025.

La empresa indicó que los resultados se publicarán el jueves 13 de noviembre de 2025, antes de la apertura del mercado. IM Cannabis opera en Israel y Alemania.

IM Cannabis (NASDAQ: IMCC)는 2025년 3분기의 운영 및 재무 실적을 발표할 예정이며, 이는 2025년 9월 30일에 종료되었습니다.

회사는 결과를 2025년 11월 13일 목요일장 개장 전 발표한다고 밝혔습니다. IM Cannabis는 이스라엘과 독일에서 운영합니다.

IM Cannabis (NASDAQ: IMCC) publiera les résultats opérationnels et financiers du troisième trimestre 2025, qui s’est terminé le 30 septembre 2025.

La société a déclaré que les résultats seront publiés le jeudi 13 novembre 2025, avant l’ouverture du marché. IM Cannabis opère en Israël et en Allemagne.

IM Cannabis (NASDAQ: IMCC) wird operative und finanzielle Ergebnisse für das dritte Quartal 2025 berichten, das am 30. September 2025 endete.

Das Unternehmen gab bekannt, dass die Ergebnisse am Donnerstag, dem 13. November 2025 vor Börsenöffnung veröffentlicht werden. IM Cannabis ist in Israel und Deutschland tätig.

IM Cannabis (NASDAQ: IMCC) ستعلن عن النتائج التشغيلية والمالية للربع الثالث من عام 2025، الذي انتهى في 30 سبتمبر 2025.

قالت الشركة إن النتائج ستصدر في الخميس 13 نوفمبر 2025، قبل افتتاح السوق. IM Cannabis تعمل في إسرائيل وألمانيا.

Positive

Negative


11/06/2025 – 07:00 AM

TORONTO and GLIL YAM, Israel, Nov. 6, 2025 /PRNewswire/ — IM Cannabis Corp. (NASDAQ: IMCC) (the “Company“, “IMCannabis“, or “IMC“), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter 2025 ended September 30, 2025, on Thursday, November 13, 2025, before the market opens.

IM Cannabis Logo

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company’s focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-third-quarter-2025-financial-results-on-thursday-november-13th-at-900am-et-302607073.html

SOURCE IM Cannabis Corp.

When will IM Cannabis (IMCC) report its Q3 2025 results?


IM Cannabis will report third quarter 2025 results on November 13, 2025, before the market opens.

What period does IM Cannabis’s Q3 2025 report cover?


The results cover the quarter ended September 30, 2025.

What types of results will IM Cannabis (IMCC) release on November 13, 2025?


The company will report operational and financial results for Q3 2025.

Which markets does IM Cannabis operate in as noted in the Q3 2025 announcement?


The company operates in Israel and Germany.

Will the November 13, 2025 IMCC announcement include a webcast or investor presentation?


This notice states the reporting date and time; it does not provide webcast or presentation details.


Im Cannabis Corp

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Latest SEC Filings

IMCC Stock Data




6.72M



2.90M



44.66%



4.31%



0.15%



Drug Manufacturers – Specialty & Generic



Healthcare



Link



Israel



Tel Aviv

 

IM Cannabis (NASDAQ: IMCC) to report results Nov 13 at 9:00am ET before market open

November 6, 2025

Rhea-AI Impact

Rhea-AI Sentiment

(Neutral)

Tags


conferences
earnings

Rhea-AI Summary

IM Cannabis (NASDAQ: IMCC) will report operational and financial results for the third quarter 2025, which ended September 30, 2025.

The company said results will be released on Thursday, November 13, 2025, before the market opens. IM Cannabis operates in Israel and Germany.

IM Cannabis (NASDAQ: IMCC) comunicherà i risultati operativi e finanziari del terzo trimestre 2025, che si è chiuso il 30 settembre 2025.

La società ha detto che i risultati saranno rilasciati giovedì 13 novembre 2025, prima dell’apertura del mercato. IM Cannabis opera in Israele e Germania.

IM Cannabis (NASDAQ: IMCC) reportará resultados operativos y financieros del tercer trimestre de 2025, que finalizó el 30 de septiembre de 2025.

La empresa indicó que los resultados se publicarán el jueves 13 de noviembre de 2025, antes de la apertura del mercado. IM Cannabis opera en Israel y Alemania.

IM Cannabis (NASDAQ: IMCC)는 2025년 3분기의 운영 및 재무 실적을 발표할 예정이며, 이는 2025년 9월 30일에 종료되었습니다.

회사는 결과를 2025년 11월 13일 목요일장 개장 전 발표한다고 밝혔습니다. IM Cannabis는 이스라엘과 독일에서 운영합니다.

IM Cannabis (NASDAQ: IMCC) publiera les résultats opérationnels et financiers du troisième trimestre 2025, qui s’est terminé le 30 septembre 2025.

La société a déclaré que les résultats seront publiés le jeudi 13 novembre 2025, avant l’ouverture du marché. IM Cannabis opère en Israël et en Allemagne.

IM Cannabis (NASDAQ: IMCC) wird operative und finanzielle Ergebnisse für das dritte Quartal 2025 berichten, das am 30. September 2025 endete.

Das Unternehmen gab bekannt, dass die Ergebnisse am Donnerstag, dem 13. November 2025 vor Börsenöffnung veröffentlicht werden. IM Cannabis ist in Israel und Deutschland tätig.

IM Cannabis (NASDAQ: IMCC) ستعلن عن النتائج التشغيلية والمالية للربع الثالث من عام 2025، الذي انتهى في 30 سبتمبر 2025.

قالت الشركة إن النتائج ستصدر في الخميس 13 نوفمبر 2025، قبل افتتاح السوق. IM Cannabis تعمل في إسرائيل وألمانيا.

Positive

Negative


11/06/2025 – 07:00 AM

TORONTO and GLIL YAM, Israel, Nov. 6, 2025 /PRNewswire/ — IM Cannabis Corp. (NASDAQ: IMCC) (the “Company“, “IMCannabis“, or “IMC“), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter 2025 ended September 30, 2025, on Thursday, November 13, 2025, before the market opens.

IM Cannabis Logo

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company’s focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its subsidiaries, which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-third-quarter-2025-financial-results-on-thursday-november-13th-at-900am-et-302607073.html

SOURCE IM Cannabis Corp.

When will IM Cannabis (IMCC) report its Q3 2025 results?


IM Cannabis will report third quarter 2025 results on November 13, 2025, before the market opens.

What period does IM Cannabis’s Q3 2025 report cover?


The results cover the quarter ended September 30, 2025.

What types of results will IM Cannabis (IMCC) release on November 13, 2025?


The company will report operational and financial results for Q3 2025.

Which markets does IM Cannabis operate in as noted in the Q3 2025 announcement?


The company operates in Israel and Germany.

Will the November 13, 2025 IMCC announcement include a webcast or investor presentation?


This notice states the reporting date and time; it does not provide webcast or presentation details.


Im Cannabis Corp

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Latest SEC Filings

IMCC Stock Data




6.72M



2.90M



44.66%



4.31%



0.15%



Drug Manufacturers – Specialty & Generic



Healthcare



Link



Israel



Tel Aviv

 

Go to Top